Headlands Technologies LLC Akero Therapeutics, Inc. Transaction History
Headlands Technologies LLC
- $939 Million
- Q4 2024
A detailed history of Headlands Technologies LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Headlands Technologies LLC holds 2,035 shares of AKRO stock, worth $102,340. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,035
Previous 6,666
69.47%
Holding current value
$102,340
Previous $191,000
70.68%
% of portfolio
0.01%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding AKRO
# of Institutions
196Shares Held
74.9MCall Options Held
210KPut Options Held
647K-
Wellington Management Group LLP Boston, MA7.38MShares$371 Million0.04% of portfolio
-
Janus Henderson Group PLC London, X07.08MShares$356 Million0.11% of portfolio
-
Rtw Investments, LP New York, NY5.92MShares$298 Million2.71% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$281 Million0.0% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$263 Million5.21% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $2.33B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...